The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives
International Journal of Molecular Sciences · 26.12.2024 · 26 (1) · 92
DOI: 10.3390/ijms26010092 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.12.2024. Verfasst von Amer Ahmed und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy. Hauptthemen laut MEDLINE: Neoplasms, Mitochondria. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 244 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, Ministero dell’Università e della Ricerca (MUR).
Abstract (Originalsprache)
Cancer cells undergo remarkable metabolic changes to meet their high energetic and biosynthetic demands. The Warburg effect is the most well-characterized metabolic alteration, driving cancer cells to catabolize glucose through aerobic glycolysis to promote proliferation. Another prominent metabolic hallmark of cancer cells is their increased reliance on glutamine to replenish tricarboxylic acid (TCA) cycle intermediates essential for ATP production, aspartate and fatty acid synthesis, and maintaining redox homeostasis. In this context, mitochondria, which are primarily used to maintain energy homeostasis and support balanced biosynthesis in normal cells, become central organelles for fulfilling the heightened biosynthetic and energetic demands of proliferating cancer cells. Mitochondrial coordination and metabolite exchange with other cellular compartments are crucial. The human SLC25 mitochondrial carrier family, comprising 53 members, plays a pivotal role in transporting TCA intermediates, amino acids, vitamins, nucleotides, and cofactors across the inner mitochondrial membrane, thereby facilitating this cross-talk. Numerous studies have demonstrated that mitochondrial carriers are altered in cancer cells, actively contributing to tumorigenesis. This review comprehensively discusses the role of SLC25 carriers in cancer pathogenesis and metabolic reprogramming based on current experimental evidence. It also highlights the research gaps that need to be addressed in future studies. Understanding the involvement of these carriers in tumorigenesis may provide valuable novel targets for drug development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari, 70125 Bari, Italy.
- Department of Biological and Environmental Sciences and Technologies, University of Salento, 73100 Lecce, Italy.
- Department of Cancer Biology and Genetics, College of Medicine, The Ohio State University and Arthur G. James Comprehensive Cancer Center, Columbus, OH 43210, USA.
- Department of Translational Biomedicine and Neuroscience, University of Bari, 70125 Bari, Italy.
- Department of Pharmacy, Health and Nutritional Sciences, University of Calabria, 87036 Rende, Italy.
ORCID-Profile: Amer Ahmed, Giorgia Natalia Iaconisi, Daria Di Molfetta, Vincenzo Coppola, Loredana Capobianco, Luigi Palmieri, Vincenza Dolce, Giuseppe Fiermonte
Förderung
- Italian Association for Cancer Research
- Ministero dell’Università e della Ricerca (MUR)
Zitieren
APA
Ahmed, A., Iaconisi, G. N., Di Molfetta, D., Coppola, V., Caponio, A., Singh, A., Bibi, A., Capobianco, L., Palmieri, L., Dolce, V., & Fiermonte, G. (2024). The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives. International Journal of Molecular Sciences, 26(1), 92. https://doi.org/10.3390/ijms26010092
Vancouver
Ahmed A, Iaconisi GN, Di Molfetta D, Coppola V, Caponio A, Singh A, et al. The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives. International Journal of Molecular Sciences. 2024;26(1):92. doi:10.3390/ijms26010092
BibTeX
@article{Ahmed2024,
author = {Ahmed, Amer and Iaconisi, Giorgia Natalia and Di Molfetta, Daria and Coppola, Vincenzo and Caponio, Antonello and Singh, Ansu and Bibi, Aasia and Capobianco, Loredana and Palmieri, Luigi and Dolce, Vincenza and Fiermonte, Giuseppe},
title = {The Role of Mitochondrial Solute Carriers SLC25 in Cancer Metabolic Reprogramming: Current Insights and Future Perspectives},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {26},
number = {1},
pages = {92},
doi = {10.3390/ijms26010092}
}
EUVIMED